JP2010538252A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010538252A5 JP2010538252A5 JP2010522447A JP2010522447A JP2010538252A5 JP 2010538252 A5 JP2010538252 A5 JP 2010538252A5 JP 2010522447 A JP2010522447 A JP 2010522447A JP 2010522447 A JP2010522447 A JP 2010522447A JP 2010538252 A5 JP2010538252 A5 JP 2010538252A5
- Authority
- JP
- Japan
- Prior art keywords
- sample
- identification method
- cypa
- identifying
- cyclophilin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0716804.0A GB0716804D0 (en) | 2007-08-29 | 2007-08-29 | Identifying organ damage |
| PCT/GB2008/002947 WO2009027703A2 (en) | 2007-08-29 | 2008-08-29 | Identifying organ damage |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010538252A JP2010538252A (ja) | 2010-12-09 |
| JP2010538252A5 true JP2010538252A5 (enExample) | 2011-10-13 |
Family
ID=38616940
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010522447A Pending JP2010538252A (ja) | 2007-08-29 | 2008-08-29 | 器官損傷の同定方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US8110371B2 (enExample) |
| EP (1) | EP2183601A2 (enExample) |
| JP (1) | JP2010538252A (enExample) |
| GB (1) | GB0716804D0 (enExample) |
| WO (1) | WO2009027703A2 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107254538A (zh) | 2008-11-12 | 2017-10-17 | 卡里斯生命科学瑞士控股有限责任公司 | 使用外来体来确定表现型的方法和系统 |
| WO2011000874A1 (en) * | 2009-07-01 | 2011-01-06 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for predicting cardiovascular mortality risk |
| KR20130056855A (ko) | 2010-03-01 | 2013-05-30 | 카리스 라이프 사이언스 룩셈부르크 홀딩스 | 치료진단용 생물학적 지표들 |
| KR20130043104A (ko) | 2010-04-06 | 2013-04-29 | 카리스 라이프 사이언스 룩셈부르크 홀딩스 | 질병용 순환 생물학적 지표들 |
| ITNA20110012A1 (it) * | 2011-03-14 | 2012-09-15 | Amal Raj Delfin Albert | Procedura di isolamento e di purificazione degli esosomi urinari per la ricerca di biomarcatori proteici |
| CN105606811A (zh) * | 2016-02-01 | 2016-05-25 | 中南大学 | 一种鼻咽癌诊断试剂盒 |
| JP7444386B2 (ja) * | 2018-06-07 | 2024-03-06 | 株式会社Ｌｓｉメディエンス | ヒト尿からのマイクロベシクルの分離方法及び分析方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4436352A1 (de) * | 1994-10-12 | 1996-04-18 | Kay Brune | Verfahren zur diagnostischen Beurteilung und Verlaufskontrolle sowie Arzneimittel zur Therapie von Schockzuständen beim Menschen |
| US6719969B1 (en) * | 1999-08-09 | 2004-04-13 | The Regents Of The University Of Michigan | Treatment of liver disease and injury with CXC chemokines |
| WO2002054081A2 (en) * | 2000-12-29 | 2002-07-11 | Oxford Glycosciences (Uk) Limited | Proteins, genes and their use for diagnosis and treatment of kidney response |
| US7469185B2 (en) * | 2002-02-04 | 2008-12-23 | Ocimum Biosolutions, Inc. | Primary rat hepatocyte toxicity modeling |
| WO2007127848A1 (en) * | 2006-04-26 | 2007-11-08 | University Of Louisville Research Foundation, Inc | Isolation of membrane vesicles from biological fluids and methods of using same |
-
2007
- 2007-08-29 GB GBGB0716804.0A patent/GB0716804D0/en not_active Ceased
-
2008
- 2008-08-29 JP JP2010522447A patent/JP2010538252A/ja active Pending
- 2008-08-29 WO PCT/GB2008/002947 patent/WO2009027703A2/en not_active Ceased
- 2008-08-29 US US12/675,479 patent/US8110371B2/en not_active Expired - Fee Related
- 2008-08-29 EP EP08788492A patent/EP2183601A2/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010538252A5 (enExample) | ||
| Sathyanarayan et al. | Elevated level of interleukin‐6 predicts organ failure and severe disease in patients with acute pancreatitis | |
| Bureau et al. | Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease | |
| Esmat et al. | Role of Helicobacter pylori in patients with HCV‐related chronic hepatitis and cirrhosis with or without hepatocellular carcinoma: possible association with disease progression | |
| Sikander et al. | Association of serotonin transporter promoter polymorphism (5-HTTLPR) with microscopic colitis and ulcerative colitis | |
| JP2013515270A5 (enExample) | ||
| Harding et al. | Biomarkers: what role do they play (if any) for diagnosis, prognosis and tumor response prediction for hepatocellular carcinoma? | |
| Muddana et al. | Current management and novel insights in acute pancreatitis | |
| Lee et al. | Subjects with diarrhea-predominant IBS have increased rectal permeability responsive to tryptase | |
| JP2007508527A5 (enExample) | ||
| Bosmans et al. | Functional mucous layer and healing of proximal colonic anastomoses in an experimental model | |
| Kasperska‐Zając et al. | Acute phase inflammatory markers in patients with non‐steroidal anti‐inflammatory drugs (NSAIDs)‐induced acute urticaria/angioedema and after aspirin challenge | |
| Smith et al. | YAP1 withdrawal in hepatoblastoma drives therapeutic differentiation of tumor cells to functional hepatocyte‐like cells | |
| Zhang et al. | CYP eicosanoid pathway mediates colon cancer-promoting effects of dietary linoleic acid | |
| Kuo et al. | Quantitative proteomic analysis of differentially expressed protein profiles involved in pancreatic ductal adenocarcinoma | |
| Kucur et al. | Extended high frequency audiometry in polycystic ovary syndrome | |
| Lin et al. | Integrated bioinformatic analysis reveals TXNRD1 as a novel biomarker and potential therapeutic target in idiopathic pulmonary arterial hypertension | |
| Fang et al. | Serpina3n/serpina3 alleviates cyclophosphamide-induced interstitial cystitis by activating the Wnt/β-catenin signal | |
| Feng et al. | Novel urinary protein panels for the non‐invasive diagnosis of non‐alcoholic fatty liver disease and fibrosis stages | |
| Cazzagon et al. | Rise and fall of HCV‐related hepatocellular carcinoma in Italy: a long‐term survey from the ITA. LI. CA centres | |
| Sengar et al. | Cell‐free Epstein–Barr virus‐DNA in patients with nasopharyngeal carcinoma: Plasma versus urine | |
| Schmid et al. | The role of biomarkers in the assessment of prostate cancer risk prior to prostate biopsy: Which markers matter and how should they be used? | |
| To et al. | The genetics of Barrett’s esophagus: a familial and population-based perspective | |
| Huang et al. | Molecular characterization of a precision-cut rat liver slice model for the evaluation of antifibrotic compounds | |
| CN111381042A (zh) | 肝细胞癌中大血管侵犯的预测方法、试剂盒及其应用 |